XML 21 R7.htm IDEA: XBRL DOCUMENT v3.25.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities    
Net income $ 236,621 $ 141,401
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization expense 84,470 81,464
Stock-based compensation expense 24,922 21,272
Deferred income taxes 5,655 (4,629)
Provision for credit losses 13,357 18,895
Amortization of fees on debt 1,238 1,236
Noncash operating lease expense 9,230 11,055
Other 1,712 1,444
Changes in assets and liabilities:    
Accounts receivable (240,429) (133,144)
Inventories, prepaid expenses, deposits and other current and long-term assets (3,643) (2,763)
Accounts payable (528) (11,585)
Accrued liabilities 8,463 (9,875)
Accrued compensation and benefits 4,149 4,834
Operating lease liability (9,583) (11,695)
Deferred revenue and other liabilities (1,142) (1,315)
Net cash provided by operating activities 134,492 106,595
Cash flows from investing activities    
Purchase of property and equipment (1,350) (1,500)
Capitalized software development costs (28,605) (30,130)
Capitalized curriculum development costs (15,451) (13,534)
Other acquisitions, loans and investments, net of distributions (1,681) (693)
Proceeds from the maturity of marketable securities 221,530 107,020
Purchases of marketable securities (227,786) (162,179)
Net cash used in investing activities (53,343) (101,016)
Cash flows from financing activities    
Repayments on finance lease obligations (29,957) (32,212)
Repurchase of restricted stock for income tax withholding (20,672) (7,597)
Net cash used in financing activities (50,629) (39,809)
Net change in cash, cash equivalents and restricted cash 30,520 (34,230)
Cash, cash equivalents and restricted cash, beginning of period 500,614 410,807
Cash, cash equivalents and restricted cash, end of period $ 531,134 $ 376,577